Trends in attention-deficit hyperactivity disorder medication use:
a retrospective observational study using population-based databases
Authors:
Sudha R Raman, Kenneth K C Man, Shahram Bahmanyar, Anick Berard, Scott Bilder, Takoua Boukhris, Greta Bushnell, Stephen Crystal, Kari Furu, Yea-Huei KaoYang, Øystein Karlstad, Helle Kieler, Kiyoshi Kubota, Edward Chia-Cheng Lai, Jaana E Martikainen, Géric Maura, Nicholas Moore, Dolores Montero, Hidefumi Nakamura, Anke Neumann, Virginia Pate, Anton Pottegård , Nicole L Pratt, Elizabeth E Roughead, Diego Macias Saint-Gerons, Til Stürmer, Chien-Chou Su, Helga Zoega, Miriam C J M Sturkenbroom, Esther W Chan, David Coghill, Patrick Ip, Ian C K Wong
Key summary:
The prevalence of ADHD medication use amongst children increased over time (2001-2015) across 14 different countries and regions. Methylphenidate was found to be the most commonly used ADHD medication in most countries, and over 90% of individuals who used ADHD medications used methylphenidate in Hong Kong. With the increasing medication use in both children and adults, there is a need to monitor medication safety and effectiveness across populations.
Reference:
Raman SR, Man KKC, Bahmanyar S, et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 2018; 5(10): 824-35.